This invention is related to a pharmaceutical composition, capable of being used for treatment or prevention of gastric mucosal diseases caused by Helicobacter pylori, said composition comprising L- glutamine and sodium guaiazulene sulfonate at a ratio of from 10 : 1 to 500 : 1.